Old Web
English
Sign In
Acemap
>
Paper
>
Characteristics of Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) in the INBUILD Trial of Nintedanib
Characteristics of Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) in the INBUILD Trial of Nintedanib
2019
Kevin R. Flaherty
Athol U. Wells
Emmanuelle Clerisme-Beaty
V Cottin
Anand Devaraj
Yoshikazu Inoue
Luca Richeldi
Simon L.F. Walsh
Rainer-Georg Goeldner
Rozsa Schlenker-Herceg
Kevin K. Brown
Keywords:
Internal medicine
Gastroenterology
Lung
Medicine
Nintedanib
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]